Reader comments on complementary and alternative medicine programs.
Lee
Colleen O
CO
D000970:Antineoplastic Agents / Q000009:adverse effects*; D002986:Clinical Trials as Topic; D004059:Diffusion of Innovation; D004353:Drug Evaluation, Preclinical; D004347:Drug Interactions; D006801:Humans; D009316:National Institutes of Health (U.S.); D008517:Phytotherapy / Q000009:adverse effects*; D012107:Research Design; D018581:Technology Transfer; D014481:United States
D000970:Antineoplastic Agents